Johnson & Johnson Medical Italia confirms its support for Italian surgeons in managing the recovery of over 1.3 million hospitalizations – of which almost 50% surgical – and of the 144.5 million missed visits in 2020 due to Covid (Gimbe Foundation numbers). In Milan, on the occasion of 39th National Congress of Acoi, Association of Italian Hospital Surgeons, the company active in the medical device sector renews a commitment “which became even stronger during the pandemic, with a dual purpose: support the system in the recovery of waiting lists and raise awareness among patients in favoring the resumption of traditional paths of prevention, diagnosis and treatment, unfortunately interrupted during the emergency “, reads a note.
“We are ready to face this important challenge together with the Italian surgeons – he declares Silvia De Dominicis, CEO of J&J Medical Italia – To recover waiting lists, we offer a system response by focusing on training, digitization and prevention, with the aim of creating an ever more efficient healthcare service at the service of patients’ needs “.
“Due to the skipped screenings, visits and surgeries during the pandemic – says President Acoi, Pierluigi Marini – today we find ourselves in a situation in which we must rush to recover the waiting lists accrued in a year and a half of emergency. We as surgeons are 120% willing to work, but we need to invest in hi-tech operating theaters, training and professional updating, also through the collaboration with private companies, which the pandemic has taught us to be fundamental to overcome moments of crisis. We have been a partner of Johnson & Johnson Medical Italia right from the start in the ‘My health cannot wait’ initiative, and we continue to collaborate on very important aspects such as the digitization of the system and staff training “.
Training is one of the main flagships of J&J – explains the company in a note – which in these days of meeting Acoi has set up a Training Village available to over 100 surgeons, with important training sessions and practices to learn new surgical techniques.
Another important space is dedicated to digitization as part of the congress, in order to present the services and digital solutions developed by the company to raise the standards of healthcare services, expand access to care for patients, improve clinical results and make the use of resources. Among the solutions present at the summit also the latest Apps of the CareForToday Monitoring suite for the remote management of the surgical patient, and the latest augmented reality and operating room management technologies, such as Visible Patient and Surgical Process Institute (Spi). Great attention is also given to the importance of prevention: the company has in fact foreseen the presence of the LifeLine awareness initiative, which focuses in particular on colorectal cancer with informative materials and an inflatable colon.
The congress will also be an opportunity to announce the project Consensus Statement on the topic of surgical site infections, entitled ‘Italian Position Paper on Ssi prevention’, which Johnson & Johnson will support through a non-conditioning contribution and which will be developed according to the Delphi method. The Consensus will be conducted on a new platform, presented by J&J at the summi Acoi: ConnectSurgery, a professional social network dedicated to colorectal surgeons, which aims to connect specialists in a digital space where it will be possible to share videos, clinical cases, clinical evidence, events and consult a whole series of pathology documents, health policy.